Connolly, James J.
Ahmed, Heidi S.
Chung, Enoch C.
Cabral, Howard J.
Nagar, Alessandra
Tami, Abigail
Schroy, Paul C. III
Mohanty, Arpan http://orcid.org/0000-0002-8408-8075
Article History
Received: 28 April 2023
Accepted: 9 November 2023
First Online: 2 December 2023
Declarations
:
: The authors have no conflicts of interest pertaining to this manuscript. In the last 24 months, A. Mohanty has received research support from Gilead, served on an advisory board for Gilead and has been the principal investigator for clinical trials conducted by Intercept, Inventiva and Novo Nordisk.<i> Disclosure</i> The authors did not receive any assistance with manuscript preparation.